BritoJP, GionfriddoM, MorrisJC, MontoriVM. 2014. Overdiagnosis of thyroid cancer and Graves' disease. Thyroid, 24:402–403.
2.
MorrisLG, SikoraAG, TostesonTD, DaviesL. 2013. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid, 23:885–891.
3.
ChenYK, LinCL, ChangYJ, ChengFT, PengCL, SungFC, ChengYH, KaoCH. 2013. Cancer risk in patients with Graves' disease: a nationwide cohort study. Thyroid, 23:879–884.
4.
NetaG, RajaramanP, Berrington de GonzalezA, DoodyMM, AlexanderBH, PrestonD, SimonSL, MeloD, MillerJ, FreedmanDM, LinetMS, SigurdsonAJ. 2013. A prospective study of medical diagnostic radiography and risk of thyroid cancer. Am J Epidemiol, 177:800–809.
5.
Aschebrook-KilfoyB, GroganRH, WardMH, KaplanE, DevesaSS. 2013. Follicular thyroid cancer incidence patterns in the United States, 1980–2009. Thyroid, 23:1015–1021.
6.
Aschebrook-KilfoyB, WardMH, SabraMM, DevesaSS. 2011. Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid, 21:125–134.
7.
Aschebrook-KilfoyB, KaplanEL, ChiuBC, AngelosP, GroganRH. 2013. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol, 20:2746–2753.
8.
KilfoyBA, DevesaSS, WardMH, ZhangY, RosenbergPS, HolfordTR, AndersonWF. 2009. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev, 18:1092–1100.
9.
Aschebrook-KilfoyB, SchechterRB, ShihYC, KaplanEL, ChiuBC, AngelosP, GroganRH. 2013. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev, 22:1252–1259.
